Total Payments
$59,455
2024 Payments
$40.06
Companies
40
Transactions
329
Medicare Patients
992
Medicare Billing
$93,186
Payment Breakdown by Category
Other$47,315 (79.6%)
Food & Beverage$6,043 (10.2%)
Travel$3,968 (6.7%)
Consulting$2,040 (3.4%)
Education$89.68 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,315 | 23 | 79.6% |
| Food and Beverage | $6,043 | 290 | 10.2% |
| Travel and Lodging | $3,968 | 9 | 6.7% |
| Consulting Fee | $2,040 | 2 | 3.4% |
| Education | $89.68 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $55,285 | 75 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $472.91 | 30 | $0 (2021) |
| Genentech USA, Inc. | $436.67 | 31 | $0 (2019) |
| Celgene Corporation | $368.35 | 15 | $0 (2018) |
| Janssen Biotech, Inc. | $338.38 | 19 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $273.87 | 12 | $0 (2020) |
| Lilly USA, LLC | $232.26 | 21 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $197.01 | 16 | $0 (2018) |
| PFIZER INC. | $162.14 | 13 | $0 (2020) |
| AbbVie Inc. | $151.78 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.06 | 1 | Boston Scientific Corporation ($40.06) |
| 2021 | $1,074 | 6 | Janssen Pharmaceuticals, Inc ($1,015) |
| 2020 | $8,512 | 30 | Janssen Pharmaceuticals, Inc ($8,161) |
| 2019 | $15,711 | 43 | Janssen Pharmaceuticals, Inc ($15,090) |
| 2018 | $14,280 | 52 | Janssen Pharmaceuticals, Inc ($13,704) |
| 2017 | $19,838 | 197 | Janssen Pharmaceuticals, Inc ($17,316) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $40.06 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2021 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Oncology | ||||||
| 01/19/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| 01/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $37.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/20/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.55 | General |
| Category: Oncology | ||||||
| 11/11/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONFOCUS | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2020 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/31/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Oncology | ||||||
| 08/11/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Oncology | ||||||
| 07/28/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/13/2020 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Hematology/Oncology | ||||||
| 07/02/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 224 | 241 | $46,035 | $11,324 |
| 2020 | 11 | 768 | 1,215 | $291,376 | $81,862 |
Total Patients
992
Total Services
1,456
Medicare Billing
$93,186
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 112 | 116 | $19,720 | $4,814 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 67 | 75 | $17,475 | $3,542 | 20.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 16 | 20 | $6,440 | $1,793 | 27.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 29 | 30 | $2,400 | $1,175 | 49.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 220 | 429 | $99,957 | $26,036 | 26.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 90 | 191 | $61,502 | $17,330 | 28.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 158 | 229 | $38,930 | $9,346 | 24.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 40 | 43 | $26,703 | $7,218 | 27.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 111 | 143 | $11,440 | $6,325 | 55.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 32 | 54 | $17,226 | $4,866 | 28.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 28 | 28 | $14,084 | $4,046 | 28.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 27 | 27 | $10,746 | $2,709 | 25.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 33 | $7,293 | $2,062 | 28.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 23 | 25 | $2,975 | $1,653 | 55.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 13 | 13 | $520.00 | $271.44 | 52.2% |
About Dr. Amy Curran, MD
Dr. Amy Curran, MD is a Medical Oncology healthcare provider based in Bryn Mawr, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699754895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Curran, MD has received a total of $59,455 in payments from pharmaceutical and medical device companies, with $40.06 received in 2024. These payments were reported across 329 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($47,315).
As a Medicare-enrolled provider, Curran has provided services to 992 Medicare beneficiaries, totaling 1,456 services with total Medicare billing of $93,186. Data is available for 2 years (2020–2021), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Bryn Mawr, PA
- Active Since 01/16/2006
- Last Updated 04/05/2017
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1699754895
Products in Payments
- XARELTO (Drug) $55,289
- OPDIVO (Biological) $342.56
- CYRAMZA (Drug) $159.50
- Revlimid (Drug) $139.30
- Avastin (Biological) $129.47
- Perjeta (Biological) $128.55
- LYNPARZA (Drug) $124.94
- ZYTIGA (Drug) $123.56
- CREON (Drug) $114.22
- TAGRISSO (Drug) $110.35
- Gonal-f (Biological) $109.94
- DARZALEX (Biological) $107.84
- IMBRUVICA (Drug) $106.98
- KEYTRUDA (Biological) $102.13
- FOUNDATIONONE (Device) $90.73
- ZEJULA (Drug) $88.27
- JAKAFI (Drug) $87.66
- VENCLEXTA (Biological) $77.03
- NINLARO (Drug) $75.32
- TASIGNA (Drug) $72.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.